Predict your next investment

Gedea Biotech company logo
HEALTHCARE | Biotechnology
gedeabiotech.com

See what CB Insights has to offer

Founded Year

2015

Stage

Grant | Alive

Total Raised

$290K

Last Raised

$50K | 3 yrs ago

About Gedea Biotech

Gedea Biotech is developing a new treatment method for vaginal infections.

Gedea Biotech Headquarter Location

Scheelevägen 2

Lund, 223 63,

Sweden

+46 (0) 708 - 91 86 81

Latest Gedea Biotech News

Gedea Biotech granted US patent

Sep 1, 2021

Gedea Biotech granted US patent Search for content, post, videos The patent can be kept in force until 2037, states the company in a press release. “The US market for treatment of vaginal infections is worth at least $300 million. Thus, the patent covering treatment and prevention of vaginal fungal infections by GDL, or pHyph strengthens Gedea’s position in one of the largest markets for treatment of these conditions. We think pHyph will replace a substantial share of the antimicrobials used for vaginal infections today,” says Annette Säfholm, Gedea Biotech’s CEO. Previously been granted a patent in Eurasia Gedea Biotech has previously been granted a patent in Eurasia (including Russia) for treatment of vaginal fungal infections using GDL (pHyph). A similar patent application is currently under evaluation by the European Patent Office (EPO) and expected to be allowed later this year. In previous clinical studies, Gedea Biotech has demonstrated promising results with pHyph for treatment of bacterial vaginosis. In addition, a confirmatory, placebo-controlled trials currently being conducted at several European sites. Photo of Annette Säfholm, Gedea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Gedea Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Gedea Biotech is included in 4 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

954 items

Startups focused on providing products and services catering to women's health and wellbeing.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

Gedea Biotech Patents

Gedea Biotech has filed 3 patents.

The 3 most popular patent topics include:

  • Animal fungal diseases
  • Bacteriology
  • Microbiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/6/2017

5/4/2021

Dosage forms, Drug delivery devices, Animal fungal diseases, Glucocorticoids, Vagina

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/6/2017

00/00/0000

00/00/0000

Grant Date

5/4/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Dosage forms, Drug delivery devices, Animal fungal diseases, Glucocorticoids, Vagina

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.